CME and ICE Press CFTC to Regulate Hyperliquid’s Perps Markets
CME Group and Intercontinental Exchange have taken their concerns about Hyperliquid directly to the Commodity Futures Trading Commission and Capitol Hill, warning that the decentralized exchange’s perpetual futures markets pose manipulation and sanctions evasion risks. HYPE is trading at $41.93, down 10.19% in 24 hours, as the regulatory pressure lands on a token that had only recently been riding institutional enthusiasm. The timing is brutal, deliberate, and not accidental.
What CME and ICE Actually Said
According to a Bloomberg report citing unnamed sources familiar with the talks, executives from both CME and ICE told US regulators that Hyperliquid’s anonymous, round-the-clock perpetual futures trading could distort global commodity benchmarks, with oil markets named as the specific pressure point. Their argument is not that Hyperliquid has already moved oil prices. The argument is that a fast-scaling, permissionless market with no surveillance infrastructure, no position limits, and no sanctions screening could become large enough to matter, and regulators should act before it does. That framing is strategic. It is also, in part, self-serving.
CME and ICE operate under deep regulatory supervision. Surveillance systems, clearing obligations, member controls, and compliance requirements are baked into their infrastructure costs. Hyperliquid operates without those costs. The commercial grievance underneath the market integrity argument is real, and it deserves to be named. But that does not make the market integrity argument wrong. Both things are true simultaneously, and anyone pretending otherwise is missing the story.
The HIP-3 Problem
Hyperliquid introduced HIP-3, its Builder-Deployed Perpetuals feature, in January 2025. The mechanism allows anyone staking 500,000 HYPE tokens, currently valued at roughly $22.2 million, to deploy new perpetual futures markets for essentially any electronically traded asset. That includes oil, gas, and other commodities that feed into global pricing benchmarks. Open interest across HIP-3 markets has climbed to over $2.5 billion as of May, according to DeFiLlama data.
This is the specific capability that alarmed CME and ICE. It is not theoretical. The markets exist, volume is building, and the product design is explicitly aimed at pulling traditional asset class exposure onto a permissionless chain. When Bitwise’s Matt Hougan said Hyperliquid proved its relevance during geopolitical volatility earlier this year, when traditional markets were closed and traders turned to it for price discovery, he was making a pitch to investors. He was also inadvertently confirming the regulators’ concern: that price discovery is already migrating to a venue outside their oversight.
HYPE will retest $32 before any recovery, as regulatory overhang suppresses the buyback premium that drove its outperformance since January.
Hyperliquid’s Defense, Examined
Hyperliquid’s policy arm pushed back, calling the concerns unfounded and arguing that onchain perpetuals offer superior transparency compared to opaque centralized venues. The transparency argument has real weight. Every trade, every liquidation, every position on Hyperliquid is publicly visible on-chain in real time, which is more than CME or ICE can claim about the full depth of their order books. The Hyperliquid Policy Center also indicated it is actively engaging with Washington on DeFi regulatory frameworks, which suggests it understands the political clock is running.
But the transparency defense has a gap. Seeing what is happening on-chain does not tell you who is doing it. Anonymous wallets transacting transparently are still anonymous wallets. The sanctions concern is not about whether the trades are visible. It is about whether the participants are screened. That distinction matters enormously to the CFTC, and Hyperliquid’s response, as reported, does not close that gap. It sidesteps it.
Structural Asymmetry: Hyperliquid Is Not an Exchange
The framing of this as a regulatory fight between “exchanges” obscures a structural difference that regulators will eventually have to address directly. CME and ICE match buyers and sellers and collect fees regardless of direction. Their revenue is neutral. Hyperliquid routes liquidity through an internal vault called HLP, the Hyperliquidity Provider, which functions as a market maker, handles liquidations, and effectively acts as the counterparty to traders. When traders lose, HLP profits. When traders win, HLP absorbs losses. That is not an exchange. That is a structured counterparty with an incentive architecture baked into the token design. The platform generates roughly $65 million in monthly fees, and a large portion flows into HYPE buybacks through its Assistance Fund, creating a feedback loop where trading volume drives fees, fees drive buybacks, and buybacks support the token price that underpins the whole system.
Arthur Hayes called HYPE a bet on Hyperliquid siphoning volume from centralized exchanges, and forecast a price of $150 by August. As the buyback mechanics have been central to HYPE’s recent price action, that forecast was always predicated on regulatory calm. That assumption just got significantly more expensive to hold.
Institutional Money Is Arriving at the Worst Possible Moment
The regulatory pressure is colliding head-on with a wave of institutional products. Bitwise launched its BHYP fund on the New York Stock Exchange on May 15, offering spot HYPE exposure with staking rewards and a 0.34% sponsor fee, waived for the first month on the first $500 million in assets. Bitwise said Hyperliquid processed $2.9 trillion in trading volume in 2025 and accounts for roughly 60% of global onchain derivatives open interest. That is a compelling pitch. It landed on the same day CME and ICE formally escalated their regulatory offensive.
Earlier in the week, 21Shares launched its THYP fund, drawing $1.8 million in trading volume on its first day and $7.42 million in cumulative net inflows. Onchain data from Lookonchain showed wallets linked to Andreessen Horowitz had accumulated roughly $67 million worth of HYPE over the prior month, with about $51 million staked. Grayscale is awaiting a decision on its own proposed Hyperliquid fund. Coinbase has become the official treasury deployer for USDC on Hyperliquid, where the stablecoin’s supply has grown to around $5 billion. The institutional infrastructure being built around HYPE is substantial. And all of it is now subject to regulatory risk that did not exist at the same intensity three months ago.
Who Loses, Who Benefits, What Comes Next
The honest answer is that CME and ICE benefit in the short term regardless of outcome. If the CFTC acts against Hyperliquid, they eliminate a fast-growing competitor. If the CFTC does nothing, they have still succeeded in generating regulatory uncertainty that slows HIP-3 adoption, spooks institutional allocators, and gives their own commodity products a compliance premium. The lobbying campaign costs them relatively little. The upside is asymmetric in their favor.
Hyperliquid loses the narrative of being the inevitable destination for on-chain capital markets. That narrative was doing real price work. The question is whether the underlying platform, its transparency, its speed, its 24/7 access, and its genuine structural advantages in on-chain price discovery, can survive a prolonged regulatory siege. Similar dynamics have played out before, as Polymarket’s long attempt to regain CFTC access demonstrates, and the timeline for resolution is measured in years, not quarters.
The most likely regulatory trajectory is not a hard ban. It is creeping compliance requirements, starting with sanctions screening obligations for new market deployments under HIP-3, then position reporting thresholds, then formal registration discussions. Each step narrows the gap between Hyperliquid’s cost structure and CME’s, which is exactly the outcome CME and ICE want. The CFTC does not need to shut Hyperliquid down. It just needs to make running permissionless commodity derivatives expensive enough that the competitive advantage erodes. That is a long game, and the two largest commodity exchanges in the world are playing it with intent.
HYPE at $41.93 is pricing in some of that uncertainty today. It is not pricing in all of it. The market tends to learn that lesson the hard way.
